MiaPaca2 and genetically matched SUIT2-NQO1-deficient (S2-NQO1-) and SUIT2-NQO1-proficient (S2-NQO1+) metastatic PDA cells were treated with various ß-lap doses (μM, 2 h), ± 12 mM MeOX, and with or without Dic for 2 h (Figs. 3A,B). Here, NQO1 is linked to Patent ductus arteriosus.